THIS IS AN OPEN-LABEL, NON-COMPARATIVE STUDY DESIGNED TO EVALUATE A SHORT COURSE OF IV ANIDULAFUNGIN, FOLLOWED OPTIONALLY BY ORAL VORICONAZOLE, FOR THE TREATMENT OF CANDIDEMIA AND INVASIVE CANDIDIASIS: